Compressus nets U.S. patent for medical message routing
Compressus has received a notice of allowance from the U.S. Patent & Trademark Office for its patent application, which represents the foundational medical message routing technologies that allow the Compressus MEDxConnect system to provide a virtualized workflow environment to healthcare providers.
The patent, entitled “Autonomous Routing of Network Messages Within a Healthcare Communication Networkf" covers MEDxConnect, which employs intelligent analysis based on the data received and required end user parameters to distribute the data in the appropriate context based on specific factors, according to the company.
Compressus of Washington, D.C., said that its MEDxConnect System acts as a communications hub, enabling various PACS, hospital information systems, RIS and other data information systems to connect and communicate, using HL7, DICOM and other standards.
The patent, entitled “Autonomous Routing of Network Messages Within a Healthcare Communication Networkf" covers MEDxConnect, which employs intelligent analysis based on the data received and required end user parameters to distribute the data in the appropriate context based on specific factors, according to the company.
Compressus of Washington, D.C., said that its MEDxConnect System acts as a communications hub, enabling various PACS, hospital information systems, RIS and other data information systems to connect and communicate, using HL7, DICOM and other standards.